Varicella (Chickenpox) Disease: Chananart Yuakyen: Icn
Varicella (Chickenpox) Disease: Chananart Yuakyen: Icn
Varicella (Chickenpox) Disease: Chananart Yuakyen: Icn
(Chickenpox)
Disease
CHANANART YUAKYEN : ICN
Definition
• 10-21 days
• Commonly 14-16 days
• May be prolonged as long as 28 days after passive
immunization against varicella
• And may be shortened in the immunodeficient.
(8-21 days)
Period of communicability
• As long as 5 days,
• But usually 1-2 days before onset of rash,
• And continuing until all lesions are crusted
(usually about 5 days).
Period of communicability (cont.)
• Preventive measures.
• Epidemic measures.
Methods of control ; Preventive measures
• Isolation
• Exclude children from school, medical offices, emergency
rooms or public places until vesicles become dry and
crusted, usually after 5 days in non-immunized children
and 1-4 days with breakthrough varicella in immunized
children;
• Exclude infected adults from workplace and avoid contact
with susceptibles.
• Quarantine.
• in places where susceptible children with known
recent exposure must remain for medicle reasons, the
risk of spread to steroid-treated or immunodeficient
patients may justify quarantine of known contacts for
at lease 10-21 days after exposure (up to 28 days if
VZIG was given).
Methods of control ;Control of patient, contacts
and the immediate environment. (cont.)
• Protection of contacts:
• Varicella vaccine is effective in preventing illness or
modifying severity if used within 3 days, and possibly
up to 5 days, of exposure; it is recommended for
susceptible persons following exposure to
varicella.
Methods of control ; Control of patient, contacts
and the immediate environment. (cont.)
• Protection of contacts: (cont.)
• VZIG
• Within 96 hours of exposure may prevent or modify
disease in susceptible close contacts of cases.
• It is available in several countries for high-risk persons
exposed to chickenpox, and indicated for newborns of
mothers who develop chickenpox within 5 days prior to
or 2 days after delivery.
• There is no assurance that administering VZIG to a
pregnant woman will prevent congenital malformations
in the fetus, but it may modifify varicella severity in the
pregnant woman.
Methods of control ; Control of patient, contacts
and the immediate environment. (cont.)
• Specific treatment: